{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:16:12Z","timestamp":1774570572648,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016190","name":"trond mohn stiftelse","doi-asserted-by":"crossref","award":["TMS2020TMT0"],"award-info":[{"award-number":["TMS2020TMT0"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005029","name":"helse vest regionalt helsef\u00f8retak","doi-asserted-by":"publisher","award":["F-11628"],"award-info":[{"award-number":["F-11628"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"norges forskningsr\u00e5d","doi-asserted-by":"publisher","award":["284930"],"award-info":[{"award-number":["284930"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"eu","award":["EU IMI115672"],"award-info":[{"award-number":["EU IMI115672"]}]},{"DOI":"10.13039\/100010661","name":"horizon 2020 framework programme","doi-asserted-by":"publisher","award":["874866 INCENTIVE"],"award-info":[{"award-number":["874866 INCENTIVE"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"horizon 2020 framework programme","doi-asserted-by":"publisher","award":["101037867 Vaccelerate"],"award-info":[{"award-number":["101037867 Vaccelerate"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the faculty of medicine, university of bergen, norway; and nanomedicines flunanoair","award":["ERA-NETet EuroNanoMed2 i JTC2016"],"award-info":[{"award-number":["ERA-NETet EuroNanoMed2 i JTC2016"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 virus, and long-term memory responses determine the risk of re-infection or boosting after vaccination. T-cellular responses are considered important for partial protection against novel variants of concern.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A prospective cohort of hospitalized (n = 14) and community (n = 38) patients with rt-PCR confirmed SARS-CoV-2 infection were recruited. Blood samples and clinical data were collected when diagnosed and at 6 months. Serum samples were analyzed for SARS-CoV-2-spike specific antibodies using ELISA (IgG, IgA, IgM), pseudotype neutralization and microneutralization assays. Peripheral blood mononuclear cells were investigated for virus-specific T-cell responses in the interferon-\u03b3 and interleukin-2 fluorescent-linked immunosorbent spot (FluroSpot) assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We found durable SARS-CoV-2 spike- and internal protein specific T-cellular responses in patients with persistent antibodies at 6 months. Significantly higher IL-2 and IFN-\u03b3 secreting T-cell responses as well as SARS-CoV-2 specific IgG and neutralizing antibodies were detected in hospitalized compared to community patients. The immune response was impacted by age, gender, comorbidity and severity of illness, reflecting clinical observations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>SARS-CoV-2 specific T-cellular and antibody responses persisted for 6 months post confirmed infection. In previously infected patients, re-exposure or vaccination will boost long-term immunity, possibly providing protection against re-infection with variant viruses.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0261979","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T18:27:52Z","timestamp":1645554472000},"page":"e0261979","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-1719","authenticated-orcid":true,"given":"Kristin G.-I.","family":"Mohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8953-8821","authenticated-orcid":true,"given":"Geir","family":"Bredholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese B.","family":"Onyango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth B.","family":"Fjelltveit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Jalloh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl A.","family":"Brokstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8527-7719","authenticated-orcid":true,"given":"Diego","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-5554","authenticated-orcid":true,"given":"Martin","family":"Mayora-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Langeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of Bergen COVID-19 research group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"issue":"10229","key":"pone.0261979.ref001","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"key":"pone.0261979.ref002","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"AB Docherty","year":"2020","journal-title":"Bmj"},{"issue":"1","key":"pone.0261979.ref003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on COVID-19 outcomes in Europe","volume":"11","author":"C Gebhard","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"7821","key":"pone.0261979.ref004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"EJ Williamson","year":"2020","journal-title":"Nature"},{"issue":"7837","key":"pone.0261979.ref005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"T Takahashi","year":"2020","journal-title":"Nature"},{"issue":"2\u20133","key":"pone.0261979.ref006","doi-asserted-by":"crossref","first-page":"J282","DOI":"10.1016\/j.jaut.2011.11.013","article-title":"Sex affects immunity","volume":"38","author":"LM Pennell","year":"2012","journal-title":"J Autoimmun"},{"issue":"3","key":"pone.0261979.ref007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/jiaa659","article-title":"Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients","volume":"223","author":"F Muecksch","year":"2021","journal-title":"The Journal of infectious diseases"},{"issue":"18","key":"pone.0261979.ref008","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1056\/NEJMoa2026116","article-title":"Humoral Immune Response to SARS-CoV-2 in Iceland","volume":"383","author":"DF Gudbjartsson","year":"2020","journal-title":"The New England journal of medicine"},{"issue":"0","key":"pone.0261979.ref009","article-title":"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination","volume":"0","author":"ECea Wall","year":"2021","journal-title":"Lancet"},{"issue":"7821","key":"pone.0261979.ref010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"C Lucas","year":"2020","journal-title":"Nature"},{"issue":"1","key":"pone.0261979.ref011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"P. Brodin","year":"2021","journal-title":"Nature medicine"},{"issue":"11","key":"pone.0261979.ref012","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"AWD Edridge","year":"2020","journal-title":"Nature medicine"},{"issue":"10","key":"pone.0261979.ref013","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41577-020-00436-4","article-title":"Not just antibodies: B cells and T cells mediate immunity to COVID-19","volume":"20","author":"RJ Cox","year":"2020","journal-title":"Nature reviews Immunology"},{"key":"pone.0261979.ref014","doi-asserted-by":"crossref","unstructured":"Anna Jeffery-Smith ARB, Sabela Lens, Chloe Rees-Spear, Monika Patel, Robin Gopal, Luke Muir, et al. SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies. Biorxiv. 2021.","DOI":"10.1101\/2021.05.30.446322"},{"issue":"11","key":"pone.0261979.ref015","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41590-020-0798-y","article-title":"T cells in COVID-19\u2014united in diversity","volume":"21","author":"L Swadling","year":"2020","journal-title":"Nature immunology"},{"issue":"1","key":"pone.0261979.ref016","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"T Sekine","year":"2020","journal-title":"Cell"},{"issue":"12","key":"pone.0261979.ref017","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"F Tang","year":"2011","journal-title":"Journal of immunology"},{"key":"pone.0261979.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2020.100014","article-title":"Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study","volume":"3","author":"K Kuwelker","year":"2021","journal-title":"The Lancet Regional Health\u2014Europe"},{"key":"pone.0261979.ref019","article-title":"Long COVID affects home-isolated young patients","author":"B MK Blomberg","year":"2021","journal-title":"Nature medicine"},{"issue":"7","key":"pone.0261979.ref020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"F Amanat","year":"2020","journal-title":"Nature medicine"},{"issue":"4","key":"pone.0261979.ref021","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/jiaa737","article-title":"SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study","volume":"223","author":"MC Trieu","year":"2021","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"pone.0261979.ref022","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"X Tian","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"pone.0261979.ref023","unstructured":"Genova CD. Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypesCecilia Di Genova. 2021."},{"key":"pone.0261979.ref024","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","author":"DS Khoury","year":"2021","journal-title":"Nature medicine"},{"issue":"4","key":"pone.0261979.ref025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"pone.0261979.ref026","article-title":"SARS-CoV-2 Elicits Robust Adaptive Immune Responses Regardless of Disease Severity","author":"SS Nielsen","year":"2020","journal-title":"bioRxiv"},{"key":"pone.0261979.ref027","article-title":"SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals","author":"Z Li","year":"2020","journal-title":"bioRxiv"},{"issue":"6529","key":"pone.0261979.ref028","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"JM Dan","year":"2021","journal-title":"Science"},{"issue":"7821","key":"pone.0261979.ref029","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"N Le Bert","year":"2020","journal-title":"Nature"},{"issue":"11","key":"pone.0261979.ref030","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1172\/JCI142004","article-title":"Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population","volume":"130","author":"SL Klein","year":"2020","journal-title":"The Journal of clinical investigation"},{"key":"pone.0261979.ref031","doi-asserted-by":"crossref","first-page":"636768","DOI":"10.3389\/fimmu.2021.636768","article-title":"Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection","volume":"12","author":"A Ansari","year":"2021","journal-title":"Frontiers in immunology"},{"issue":"48","key":"pone.0261979.ref032","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"D Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"issue":"7","key":"pone.0261979.ref033","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/oby.22831","article-title":"High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation","volume":"28","author":"A Simonnet","year":"2020","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"pone.0261979.ref034","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1111\/cob.12403","article-title":"Obesity: A critical risk factor in the COVID-19 pandemic","volume":"10","author":"S Kwok","year":"2020","journal-title":"Clin Obes"},{"key":"pone.0261979.ref035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"J Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"8","key":"pone.0261979.ref036","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"QX Long","year":"2020","journal-title":"Nature medicine"},{"key":"pone.0261979.ref037","doi-asserted-by":"crossref","unstructured":"Fajnzylber J RJ, Coxen, K, \u2026Li J. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nature 2021.","DOI":"10.21203\/rs.3.rs-43878\/v1"},{"issue":"2","key":"pone.0261979.ref038","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1473-3099(20)30466-7","article-title":"Seroconversion in household members of COVID-19 outpatients","volume":"21","author":"RJ Cox","year":"2021","journal-title":"The Lancet infectious diseases"},{"issue":"54","key":"pone.0261979.ref039","doi-asserted-by":"crossref","first-page":"eabe0240","DOI":"10.1126\/sciimmunol.abe0240","article-title":"Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome","volume":"5","author":"K R\u00f6ltgen","year":"2020","journal-title":"Science Immunology"},{"issue":"12","key":"pone.0261979.ref040","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","volume":"5","author":"J Seow","year":"2020","journal-title":"Nat Microbiol"},{"key":"pone.0261979.ref041","doi-asserted-by":"crossref","unstructured":"Castillo-Olivares J W, D, Ferrari M, Chan A, Smith P, Nadesalingam A, Paloniemi M, et al. Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease. 2021.","DOI":"10.1101\/2021.05.21.21257572"},{"issue":"10282","key":"pone.0261979.ref042","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)00527-4","article-title":"WHO International Standard for anti-SARS-CoV-2 immunoglobulin","volume":"397","author":"PA Kristiansen","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"pone.0261979.ref043","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02107-20","article-title":"Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate","volume":"58","author":"A Addetia","year":"2020","journal-title":"Journal of clinical microbiology"},{"key":"pone.0261979.ref044","doi-asserted-by":"crossref","unstructured":"To KK, Hung IF, Ip JD, Chu AW, Chan WM, Tam AR, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020.","DOI":"10.1093\/cid\/ciaa1275"},{"issue":"1","key":"pone.0261979.ref045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1473-3099(20)30764-7","article-title":"Genomic evidence for reinfection with SARS-CoV-2: a case study","volume":"21","author":"RL Tillett","year":"2021","journal-title":"The Lancet infectious diseases"},{"issue":"52","key":"pone.0261979.ref046","article-title":"Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients","volume":"5","author":"AS Iyer","year":"2020","journal-title":"Sci Immunol"},{"issue":"52","key":"pone.0261979.ref047","doi-asserted-by":"crossref","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"B Isho","year":"2020","journal-title":"Science Immunology"},{"key":"pone.0261979.ref048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejim.2021.05.010","article-title":"SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors","volume":"89","author":"E Terpos","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"10","key":"pone.0261979.ref049","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"S Sridhar","year":"2013","journal-title":"Nature medicine"},{"key":"pone.0261979.ref050","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1038\/ncomms7833","article-title":"Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells","volume":"6","author":"Z Wang","year":"2015","journal-title":"Nature communications"},{"issue":"7833","key":"pone.0261979.ref051","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"J Braun","year":"2020","journal-title":"Nature"},{"issue":"7","key":"pone.0261979.ref052","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"A Grifoni","year":"2020","journal-title":"Cell"},{"issue":"6522","key":"pone.0261979.ref053","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"KW Ng","year":"2020","journal-title":"Science"},{"key":"pone.0261979.ref054","article-title":"Cross-reactive antibody immunity against SARS-CoV-2 in children and adults","author":"E Fraley","year":"2021","journal-title":"Cell Mol Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T18:28:42Z","timestamp":1645554522000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261979"}},"subtitle":[],"editor":[{"given":"Jishnu","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0261979","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]}}}